• Contact us
  • Advertise with us
  • Login
Tashi Pharma
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • All
    • EDQM
    • EMA
    • European Commision
    • Health Canada
    • Medsafe
    • MHRA
    • SAHPRA
    • US FDA
    FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

    FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

    Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

    US FDA publishes guidance on Initiation of Voluntary Recalls

    EMA publishes Q & A for Bootstrap methodology for f2 similarity factor

    EMA publishes Q & A on Bootstrap methodology for f2 similarity factor

    US FDA publishes product-specific guidances to facilitate generic drug development

    US FDA publishes product-specific guidances to facilitate generic drug development

    Clinical Trials Regulation comes into effect in the EU

    New Clinical Trials Regulation comes into effect in the EU

    Reflection paper Forecasting demand for medicinal products in the EU_EEA

    EMA publishes reflection paper on forecasting demand for medicinal products in the EU/EEA

    Trending Tags

    • Pharma
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • Clinical
    • bioanalytical
  • Webinar
No Result
View All Result
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • All
    • EDQM
    • EMA
    • European Commision
    • Health Canada
    • Medsafe
    • MHRA
    • SAHPRA
    • US FDA
    FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

    FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

    Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

    US FDA publishes guidance on Initiation of Voluntary Recalls

    EMA publishes Q & A for Bootstrap methodology for f2 similarity factor

    EMA publishes Q & A on Bootstrap methodology for f2 similarity factor

    US FDA publishes product-specific guidances to facilitate generic drug development

    US FDA publishes product-specific guidances to facilitate generic drug development

    Clinical Trials Regulation comes into effect in the EU

    New Clinical Trials Regulation comes into effect in the EU

    Reflection paper Forecasting demand for medicinal products in the EU_EEA

    EMA publishes reflection paper on forecasting demand for medicinal products in the EU/EEA

    Trending Tags

    • Pharma
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • Clinical
    • bioanalytical
  • Webinar
No Result
View All Result
No Result
View All Result
Home Interview

An Entrepreneur who started at different location……….

Mr Prakash Jotaniya, Managing Director at HealthGenic Chemicals Pvt Ltd. In this Interview, Prakash Jotaniya narrates his journey on setting up a manufacturing unit at not so conventional place for pharmaceutical manufacturing

PRN by PRN
April 24, 2021
in Interview
296 22
0
An Entrepreneur who started at different location……….
205
SHARES
489
VIEWS

You are the first generation pharmaceutical entrepreneur. How is your journey so far ?

Prakash Jotaniya: My journey has been exciting with so much learning & like a roller coaster. It has been challenging & not so easy. From 2006 to 2010, I did my B.Pharm from RK university. After finishing my B.Pharm, I started doing job in Sun Pharma. After doing two years’ job, I did by my MBA in international marketing. Once MBA was over, I joined Sanofi India as marketing manager. Later on I quit the Job in Sanofi India & started my own venture named Healthgenic Chemicals in Morbi, Gujarat. Initially we did not know much about the technicalities. I took guidance from my friends, teachers, colleagues on number of aspects like how to start API industry, how to run a manufacturing unit, what are the rules & regulation. It is almost 2 years now & it has been fascinating journey so far.

You started the company at a different location than most popular areas of pharmaceuticals in Gujarat. What was your idea behind this ?

Prakash Jotaniya: Yes, our manufacturing unit is located at Morbi, which falls in Saurashtra region of Gujarat & It is not a notified area for Pharmaceuticals. Morbi is known for ceramic industry but I can see that pharmaceutical industry is growing here as well. I started my company here so more & more entrepreneurs can be attracted here. Right now, there are around 6-7 pharmaceutical manufacturing unit around Rajkot. I believe that if you have the right attitude & skill set then you can grow in any part of country.

 

 

(Image: HealthGenic Chemicals Pvt Ltd located at Morbi, Gujarat)

Does location give you disadvantage in terms of business?

Prakash Jotaniya: Yes, there are difficulties but you cannot count it as a disadvantage.  We do face  some challenges like distribution of goods/availability of raw materials/maintenance of spare parts/getting good talent etc. but we are overcoming those challenges. If you have good quality product & good service, then you can overcome such challenges.  At the end of the day you have to make your customer happy.

As they say, ‘Where there is a will, there is a way’

What challenges did you face while setting up a manufacturing unit ?

Prakash Jotaniya: There were lot of challenges like building & structure of facility, environment & pollution clearance, Inventory & project management.

You are in to API & intermediate manufacturing. How big is the market? How much will the market grow in next 5 years as per your calculation ?

Prakash Jotaniya: Next 5 years, API market will ground around 10%. If you consider China, then China is de-growing at the moment as compared to India. China is likely to grow around 5-6% in next 5 years while India will grow around 10%. India is likely to have robust growth in terms of API. Earlier, we were dependent on China but situation is becoming reverse. Now a days, Indian companies are also sending API to China. API market is likely to grow faster than any other market. India is likely to be in top five exporting countries for API in next 2-3 years. India may move to top three in next 6-7 years for exports of API. I feel that Indian pharmaceutical market is likely to have robust growth.

You have worked in marketing field as well. What will you consider more difficult marketing or manufacturing ?

Prakash Jotaniya: That is tricky question for me. I like both the fields. After finishing my B.Pharm, I thought that I will work in manufacturing sector. However, from my inner capability I came to know that marketing job is more suitable to me. I really enjoyed marketing experience in my previous organizations. That’s why I have selected marketing portfolio in my organization.

What will be your advice to young entrepreneurs who wants to start their journey in manufacturing sector ?

Prakash Jotaniya: First start with market research of your work. Try to do ground work before your start. Try & ask some questions to yourself like what to do, what not do, how to do. Identify your customer. Identify resources for your raw material. Identity what will be market trend for next 5-10 years. Identify your directions.

Have you set goals for your company & yourself? For example I want to see my company at particular level in next 5 year or 10 years.

Prakash Jotaniya: Yes, every organization is having some dream & vision to reach at some level in certain time. Currently, we are state GMP certified plant & we have designed our plant to comply with global regulatory standard like WHO GMP, US FDA, EU GMP.  Our short term vision is to become leading API manufacturer & supplier in Saurashtra & Gujarat region. We want to apply WHO GMP & GLP in next 2-3 years. Long term is goal to pass the audit of regulated market like US FDA & EU GMP.

What is your vision for the company ?

Prakash Jotaniya: To provide professional service with quality API.

Tags: InterviewPharma NewspharmacyPharmareg News
Previous Post

Hester launches a range of Herbal Veterinary Products

Next Post

BIOLOGICAL E. LIMITED GETS CDSCO NOD TO START PHASE III CLINICAL TRIAL OF ITS COVID-19 VACCINE CANDIDATE

PRN

PRN

Related Posts

How UK is providing large investment opportunity for life sciences sector
Interview

How UK is providing large investment opportunity for life sciences sector

by PRN
May 30, 2021
In this Interview, Milan Patel narrates his journey with Troikaa pharmaceuticals, passion for innovation, upcoming exciting developments and guidance for pharmacy students & young entrepreneurs.
Interview

An Entrepreneur Known for Innovations…..

by PRN
May 16, 2021
Mr Ramiz Nathani, Co-Founder & COO of Researcher
Interview

An Entrepreneur who is a Researcher as well…..

by PRN
May 16, 2021
An Entrepreneur who is digitizing the Pharmaceutical Manufacturing…….
Interview

An Entrepreneur who is digitizing the Pharmaceutical Manufacturing…….

by PRN
May 8, 2021
Pharmaceutical Entrepreneur Who Began Early…..
Interview

Pharmaceutical Entrepreneur Who Began Early…..

by PRN
April 10, 2021
Next Post
BIOLOGICAL E. LIMITED GETS CDSCO NOD TO START PHASE III CLINICAL TRIAL OF ITS COVID-19 VACCINE CANDIDATE

BIOLOGICAL E. LIMITED GETS CDSCO NOD TO START PHASE III CLINICAL TRIAL OF ITS COVID-19 VACCINE CANDIDATE

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

Zydus to launch Oxemia

Zydus to launch Oxemia (Desidustat) a treatment for Anemia in patients with Chronic Kidney Disease (CKD)

March 7, 2022
FDA Urges Companies to be 'Recall Ready’ to Protect Public Health as Part of Final Guidance for Voluntary Recalls

US FDA Urges Companies to be ’Recall Ready’ to Protect Public Health

March 6, 2022
FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

March 5, 2022
Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

US FDA publishes guidance on Initiation of Voluntary Recalls

March 5, 2022
Kilitch Drugs Commences Rs. 100 Crore New Facility Expansion Plan

Kilitch Drugs Commences Rs. 100 Crore New Facility Expansion Plan

March 5, 2022

Browse by Category

  • Articles
  • Company Focus
  • EDQM
  • EMA
  • European Commision
  • Global Pharma News
  • Guideline News
  • Health Canada
  • Indian Pharma News
  • Interview
  • Medsafe
  • MHRA
  • SAHPRA
  • US FDA
  • Webinar

Browse by Tags

Abbott Alembic alkem Amgen Amneal AstraZeneca bayer biocon Biogen BioNTech Bristol Myers Squibb cipla covid Daiichi Sankyo drreddy Eli Lilly fda Gilead glenmark gsk Incyte Janssen Jubilant lupin MHRA Moderna Natco Novartis Novavax novo nordisk oncology Panacea Biotech Pfizer pharmacy Pharma News Pharmareg News Remdesivir roche sanofi Sun pharma Teva usfda Vaccine Viatris zydus

Contact us

Address:Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002.
Phone:+91 8511586232, +91 9029066605
Email:author@pharmaregnews.com

Browse by Tag

Abbott Alembic alkem Amgen Amneal AstraZeneca bayer biocon Biogen BioNTech Bristol Myers Squibb cipla covid Daiichi Sankyo drreddy Eli Lilly fda Gilead glenmark gsk Incyte Janssen Jubilant lupin MHRA Moderna Natco Novartis Novavax novo nordisk oncology Panacea Biotech Pfizer pharmacy Pharma News Pharmareg News Remdesivir roche sanofi Sun pharma Teva usfda Vaccine Viatris zydus

Advertise with us

© 2021 - Pharmaregnews.com. Developed by YESWEUS.

No Result
View All Result
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • bioanalytical
    • Clinical
  • Webinar
  • Contact us
  • Advertise with us
  • Login

© 2021 - Pharmaregnews.com. Developed by YESWEUS.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?